Kendra Adams C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Kendra Adams is Chief Financial Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 82,039 shares of CCCC, which is worth approximately $478,287. The most recent transaction as insider was on Feb 14, 2024, when has been sold 36,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82K
0% 3M change
n/a 12M change
Total Value Held $478,287

Kendra Adams Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
BUY
Grant, award, or other acquisition
-
36,700 Added 30.91%
82,039 Common Stock
Feb 13 2024
SELL
Payment of exercise price or tax liability
$8,495 $6.53 p/Share
1,301 Reduced 2.79%
45,339 Common Stock
Sep 18 2023
BUY
Grant, award, or other acquisition
-
25,000 Added 34.9%
46,640 Common Stock
KA

Kendra Adams

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC